Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 3, pp 399-405, issn 0344-5704, 7 p.Article

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung CancerFUKUDO, Masahide; IKEMI, Yasuaki; KATSURA, Toshiya et al.Clinical pharmacokinetics. 2013, Vol 52, Num 7, pp 593-609, issn 0312-5963, 17 p.Article

Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationTOGASHI, Yosuke; MASAGO, Katsuhiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 1089-1092, issn 0344-5704, 4 p.Article